News Image

Jeune Announces Positive Results and Significant Aesthetic Improvements from Phase 1 Study of KB304 for Moderate to Severe Wrinkles of the Décolleté

Provided By GlobeNewswire

Last update: Jul 24, 2025

KB304 designed to deliver collagen and elastin to restore skin naturally

Conference call to discuss results scheduled for Thursday, July 24, 2025 at 4:30pm ET

Read more at globenewswire.com

KRYSTAL BIOTECH INC

NASDAQ:KRYS (9/17/2025, 8:00:02 PM)

After market: 154.05 0 (0%)

154.05

-0.33 (-0.21%)



Find more stocks in the Stock Screener

Follow ChartMill for more